Novel Model for Predicting Vaccine Efficacy and Safety

An innovative biomimetic model of the human immune system known as MIMIC® system has been developed by scientists.

An innovative biomimetic model of the human immune system known as MIMIC® system has been developed by scientists. This model facilitates faster, more effective vaccine development.

"Our goal is to increase the likelihood of success within the clinic– to make better drugs and vaccines and get them into the marketplace and to the patients faster," says William Warren, PhD, Head of the VaxDesign Campus, Sanofi Pasteur. "This in vitro human immune system enables us to measure vaccine efficacy earlier and more predictably."

Children Food Allergies – Peanut Allergy – Egg Allergy - Milk Allergy
If you are allergic to certain food items-Watch out for what you eat

The MIMIC® platform represents a truly disruptive technology for the study of vaccines and other biologics with immunomodulatory potential, as it provides a novel in vitro model for evaluating human immune responses against candidate drugs, adjuvants, and vaccines. It has shown game-changing advantages over conventional approaches to safety and efficacy testing.

Source-Eurekalert

Quiz on Allergy
Every season can be an allergy season, depending on what you're allergic to. - Clara Chung

'Next-Gen' Vaccines Will be Developed by Manipulating the Immune System
Scientists have discovered how a vital immune cell recognizes dead and damaged body cells.

Measles-bearing Vaccines Not Related to Worse Risk of Febrile Seizures in Kids 4 to 6
Vaccines for measles were not linked to an augmented risk of febrile seizures between 4 and 6 year olds during the six weeks after vaccination, states study.